Investment

The dearth of other funding is bringing angel investors onto the frontline in the risky business of seeding startups.

The country may be experiencing the deepest recession in the Eurozone, but 32 technology companies in Ireland are bucking the trend, according to a new survey.

Even the largest pharma companies will need to step outside their sector and collaborate with other organisations, according to new research by PwC.

The business angels network Oxford Investment Opportunity Network has enjoyed a record breaking time, investing £3.15 million in 15 companies.

With investors keeping their money in their pockets, and the IPO window nailed shut, the 33 year-old model of biotech funding is outdated, says a new report.

As life sciences investors shy away from drug development and opt for lower-risk devices and diagnostics, what can Europe learn from Israel’s experience?

Private equity and venture capital investment by UK-based firms in 2008 fell below £20 billion for the first time since 2005, says a new report.